Australia markets close in 4 hours 45 minutes

StageZero Life Sciences Ltd. (SZLSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01280.0000 (0.00%)
At close: 09:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,621
3,795
5,068
4,152
Cost of revenue
4,647
4,199
3,891
3,456
Gross profit
-26.086
-403.745
1,177
695.555
Operating expenses
Research development
895.369
351.992
774.536
218.696
Selling general and administrative
7,854
6,652
8,222
3,689
Total operating expenses
9,153
7,430
9,308
4,051
Operating income or loss
-9,179
-7,834
-8,131
-3,355
Interest expense
205.487
219.208
200.308
320.422
Total other income/expenses net
5,171
-3,297
847.232
-2,844
Income before tax
-4,213
-11,415
-7,484
-6,864
Income tax expense
0
0
0
-
Income from continuing operations
-4,213
-11,415
-7,484
-6,864
Net income
-4,213
-11,415
-7,484
-6,864
Net income available to common shareholders
-4,213
-11,415
-7,484
-6,864
Basic EPS
-0.12
-0.11
-0.11
-0.15
Diluted EPS
-0.12
-0.11
-0.11
-0.15
Basic average shares
109,978
99,426
70,716
44,821
Diluted average shares
109,978
99,426
70,716
44,821